Skip to main content
Top
Published in: Annals of Surgical Oncology 6/2015

01-06-2015 | Gynecologic Oncology

Success Factors of Laparoscopic Nerve-sparing Radical Hysterectomy for Preserving Bladder Function in Patients with Cervical Cancer: A Protocol-Based Prospective Cohort Study

Authors: Hee Seung Kim, MD, Tae Hun Kim, MD, Dong Hoon Suh, MD, Sang Youn Kim, MD, Min A. Kim, MD, PhD, Chang Wook Jeong, MD, PhD, Kyoung Sup Hong, MD, Yong Sang Song, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2015

Login to get access

Abstract

Background

Success factors of laparoscopic nerve-sparing radical hysterectomy (LNRH) to preserve bladder function are little known despite its widespread use. Thus, we conducted a protocol-based prospective cohort study to evaluate clinicopathologic factors for preserving autonomic nerves and its impact on duration of postoperative catheterization (DPC).

Methods

From 2012 to 2014, 30 patients with stage IB1 to IIA2 cervical cancer were recruited prospectively to undergo LNRH. All procedures were performed on the left side of the patients by one gynecologic oncologist. Extent of resection and preservation of autonomic nerves were documented in the protocol during LNRH.

Results

All patients received laparoscopic type C1 radical hysterectomy, where extent of resection and preservation of autonomic nerves were not different between the right and left sides. Stage IB1 disease was associated with the reduced risk of injury of the left junctions between the hypogastric and the splanchnic nerves; between the splanchnic nerve and the vesical branch of the pelvic plexus (S–V junction) (adjusted odds ratios, 0.06 and 0.06; 95 % confidence intervals, 0.01–0.92 and 0.01–0.48); the right S–V junction with marginal significance (adjusted odds ratio, 0.18; 95 % confidence interval, 0.03–1.06). Furthermore, bilateral preservation of autonomic nerves decreased DPC significantly when compared with failure or unilateral preservation (median, 6 days vs. 34 days or 57 days; P < 0.05).

Conclusions

LNRH has a higher likelihood of its success in stage IB1 than in stage IB2 to IIA disease. Moreover, preservation of bilateral autonomic nerves reduces DPC significantly in comparison with failure or unilateral preservation.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hockel M, Horn LC, Manthey N, et al. Resection of the embryologically defined uterovaginal (Mullerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol. 2009;10:683–92.CrossRefPubMed Hockel M, Horn LC, Manthey N, et al. Resection of the embryologically defined uterovaginal (Mullerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol. 2009;10:683–92.CrossRefPubMed
3.
go back to reference Hockel M, Hentschel B, Horn LC. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Lancet Oncol. 2014;15:445–56.CrossRefPubMed Hockel M, Hentschel B, Horn LC. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis. Lancet Oncol. 2014;15:445–56.CrossRefPubMed
4.
go back to reference Lee TY, Jeung YJ, Lee CJ, et al. Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer. Obstet Gynecol Sci. 2013;56:15–21.CrossRefPubMedCentralPubMed Lee TY, Jeung YJ, Lee CJ, et al. Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer. Obstet Gynecol Sci. 2013;56:15–21.CrossRefPubMedCentralPubMed
5.
go back to reference Kim HS, Kim JY, Park NH, et al. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1–IIA cervical cancer. Gynecol Oncol. 2010;119:217–24.CrossRefPubMed Kim HS, Kim JY, Park NH, et al. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1–IIA cervical cancer. Gynecol Oncol. 2010;119:217–24.CrossRefPubMed
6.
go back to reference Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–103.CrossRefPubMed Quinn MA, Benedet JL, Odicino F, et al. Carcinoma of the cervix uteri. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S43–103.CrossRefPubMed
7.
go back to reference Suh DH, Kim JW, Kang S, et al. Major clinical research advances in gynecologic cancer in 2013. J Gynecol Oncol. 2014;25:236–48. Suh DH, Kim JW, Kang S, et al. Major clinical research advances in gynecologic cancer in 2013. J Gynecol Oncol. 2014;25:236–48.
8.
go back to reference Benedetti-Panici P, Zullo MA, Plotti F, et al. Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3–4 radical hysterectomy. Cancer. 2004;100:2110–7.CrossRefPubMed Benedetti-Panici P, Zullo MA, Plotti F, et al. Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3–4 radical hysterectomy. Cancer. 2004;100:2110–7.CrossRefPubMed
9.
go back to reference Chen GD, Lin LY, Wang PH, Lee HS. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol. 2002;85:292–7.CrossRefPubMed Chen GD, Lin LY, Wang PH, Lee HS. Urinary tract dysfunction after radical hysterectomy for cervical cancer. Gynecol Oncol. 2002;85:292–7.CrossRefPubMed
10.
go back to reference Zullo MA, Manci N, Angioli R, et al. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol. 2003;48:287–93.CrossRefPubMed Zullo MA, Manci N, Angioli R, et al. Vesical dysfunctions after radical hysterectomy for cervical cancer: a critical review. Crit Rev Oncol Hematol. 2003;48:287–93.CrossRefPubMed
11.
go back to reference Pieterse QD, Kenter GG, Maas CP, et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer. 2013;23:1717–25.CrossRefPubMed Pieterse QD, Kenter GG, Maas CP, et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer. 2013;23:1717–25.CrossRefPubMed
12.
go back to reference Possover M, Stober S, Plaul K, Schneider A. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154–7.CrossRefPubMed Possover M, Stober S, Plaul K, Schneider A. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154–7.CrossRefPubMed
13.
go back to reference Querleu D, Narducci F, Poulard V, et al. Modified radical vaginal hysterectomy with or without laparoscopic nerve-sparing dissection: a comparative study. Gynecol Oncol. 2002;85:154–8.CrossRefPubMed Querleu D, Narducci F, Poulard V, et al. Modified radical vaginal hysterectomy with or without laparoscopic nerve-sparing dissection: a comparative study. Gynecol Oncol. 2002;85:154–8.CrossRefPubMed
14.
go back to reference Ceccaroni M, Roviglione G, Spagnolo E, et al. Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy: a multicenter comparative study. Anticancer Res. 2012;32:581–8.PubMed Ceccaroni M, Roviglione G, Spagnolo E, et al. Pelvic dysfunctions and quality of life after nerve-sparing radical hysterectomy: a multicenter comparative study. Anticancer Res. 2012;32:581–8.PubMed
15.
go back to reference Bogani G, Cromi A, Uccella S, et al. Nerve-sparing versus conventional laparoscopic radical hysterectomy: a minimum 12 months’ follow-up study. Int J Gynecol Cancer. 2014;24:787–93.CrossRefPubMed Bogani G, Cromi A, Uccella S, et al. Nerve-sparing versus conventional laparoscopic radical hysterectomy: a minimum 12 months’ follow-up study. Int J Gynecol Cancer. 2014;24:787–93.CrossRefPubMed
16.
go back to reference Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111:S33–41.CrossRefPubMed Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111:S33–41.CrossRefPubMed
17.
go back to reference Dursun P, Ayhan A, Kuscu E. Nerve-sparing radical hysterectomy for cervical carcinoma. Crit Rev Oncol Hematol. 2009;70:195–205.CrossRefPubMed Dursun P, Ayhan A, Kuscu E. Nerve-sparing radical hysterectomy for cervical carcinoma. Crit Rev Oncol Hematol. 2009;70:195–205.CrossRefPubMed
18.
19.
go back to reference Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256–62.CrossRefPubMed Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256–62.CrossRefPubMed
20.
go back to reference Rob L, Halaska M, Robova H. Nerve-sparing and individually tailored surgery for cervical cancer. Lancet Oncol. 2010;11:292–301.CrossRefPubMed Rob L, Halaska M, Robova H. Nerve-sparing and individually tailored surgery for cervical cancer. Lancet Oncol. 2010;11:292–301.CrossRefPubMed
21.
go back to reference Charoenkwan K, Pranpanas S. Prevalence and characteristics of late postoperative voiding dysfunction in early-stage cervical cancer patients treated with radical hysterectomy. Asian Pac J Cancer Prev. 2007;8:387–9.PubMed Charoenkwan K, Pranpanas S. Prevalence and characteristics of late postoperative voiding dysfunction in early-stage cervical cancer patients treated with radical hysterectomy. Asian Pac J Cancer Prev. 2007;8:387–9.PubMed
22.
go back to reference Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340:1383–9.CrossRefPubMed Bergmark K, Avall-Lundqvist E, Dickman PW, et al. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med. 1999;340:1383–9.CrossRefPubMed
23.
go back to reference Kim HS, Choi CH, Lim MC, et al. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study. Ann Surg Oncol. 2012;19:1973–9.CrossRefPubMed Kim HS, Choi CH, Lim MC, et al. Safe criteria for less radical trachelectomy in patients with early-stage cervical cancer: a multicenter clinicopathologic study. Ann Surg Oncol. 2012;19:1973–9.CrossRefPubMed
24.
go back to reference Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.CrossRefPubMed Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.CrossRefPubMed
25.
go back to reference van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39–45.CrossRefPubMed van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39–45.CrossRefPubMed
26.
go back to reference Kato K, Suzuka K, Osaki T, Tanaka N. Unilateral or bilateral nerve-sparing radical hysterectomy: a surgical technique to preserve the pelvic autonomic nerves while increasing radicality. Int J Gynecol Cancer. 2007;17:1172–8.CrossRefPubMed Kato K, Suzuka K, Osaki T, Tanaka N. Unilateral or bilateral nerve-sparing radical hysterectomy: a surgical technique to preserve the pelvic autonomic nerves while increasing radicality. Int J Gynecol Cancer. 2007;17:1172–8.CrossRefPubMed
27.
go back to reference Tseng CJ, Shen HP, Lin YH, et al. A prospective study of nerve-sparing radical hysterectomy for uterine cervical carcinoma in Taiwan. Taiwan J Obstet Gynecol. 2012;51:55–9.CrossRefPubMed Tseng CJ, Shen HP, Lin YH, et al. A prospective study of nerve-sparing radical hysterectomy for uterine cervical carcinoma in Taiwan. Taiwan J Obstet Gynecol. 2012;51:55–9.CrossRefPubMed
28.
go back to reference Liang JT, Chien CT, Chang KJ, et al. Neurophysiological basis of sympathetic nerve-preserving surgery for lower rectal cancer—a canine model. Hepatogastroenterology. 1998;45:2206–14.PubMed Liang JT, Chien CT, Chang KJ, et al. Neurophysiological basis of sympathetic nerve-preserving surgery for lower rectal cancer—a canine model. Hepatogastroenterology. 1998;45:2206–14.PubMed
29.
go back to reference Chen C, Li W, Li F, et al. Classical and nerve-sparing radical hysterectomy: an evaluation of the nerve trauma in cardinal ligament. Gynecol Oncol. 2012;125:245–51.CrossRefPubMed Chen C, Li W, Li F, et al. Classical and nerve-sparing radical hysterectomy: an evaluation of the nerve trauma in cardinal ligament. Gynecol Oncol. 2012;125:245–51.CrossRefPubMed
30.
go back to reference Ditto A, Martinelli F, Mattana F, et al. Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: an observational study. Ann Surg Oncol. 2011;18:3469–78.CrossRefPubMed Ditto A, Martinelli F, Mattana F, et al. Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: an observational study. Ann Surg Oncol. 2011;18:3469–78.CrossRefPubMed
32.
go back to reference Ditto A, Martinelli F, Ramondino S, et al. Class II versus class III radical hysterectomy in early cervical cancer: an observational study in a tertiary center. Eur J Surg Oncol. 2014;40:883–90.CrossRefPubMed Ditto A, Martinelli F, Ramondino S, et al. Class II versus class III radical hysterectomy in early cervical cancer: an observational study in a tertiary center. Eur J Surg Oncol. 2014;40:883–90.CrossRefPubMed
Metadata
Title
Success Factors of Laparoscopic Nerve-sparing Radical Hysterectomy for Preserving Bladder Function in Patients with Cervical Cancer: A Protocol-Based Prospective Cohort Study
Authors
Hee Seung Kim, MD
Tae Hun Kim, MD
Dong Hoon Suh, MD
Sang Youn Kim, MD
Min A. Kim, MD, PhD
Chang Wook Jeong, MD, PhD
Kyoung Sup Hong, MD
Yong Sang Song, MD, PhD
Publication date
01-06-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 6/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4197-1

Other articles of this Issue 6/2015

Annals of Surgical Oncology 6/2015 Go to the issue